Chrysemys picta bellii isolate RCT428 chromosome 19, Chrysemys_picta_BioNano-3.0.4, whole genome shotgun sequence.
Chrysemys picta bellii (western painted turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Chrysemys.
Physical Mapping and Refinement of the Painted Turtle Genome (Chrysemys picta) Inform Amniote Genome Evolution and Challenge Turtle-Bird Chromosomal Conservation
REFSEQ INFORMATION: The reference sequence is identical to\nCM002668.2.\nOn Aug 10, 2021 this sequence version replaced NC_024231.1.\nAssembly name: Chrysemys_picta_BioNano-3.0.4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Painted turtle genome\nsequencing consortium on 2020/08/21. The original whole-genome\nshotgun project has the accession AHGY00000000.3.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Painted turtle genome sequencing\n consortium\nAssembly Method :: Newbler v. 2.6\nAssembly Name :: Chrysemys_picta_BioNano-3.0.4\nGenome Coverage :: 19.2x\nSequencing Technology :: 454 Life Sciences\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chrysemys picta Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
small lake 1.3 miles south of Potholes Reservoir
Derived by automated computational analysis using gene prediction method: Gnomon.
THUMP domain containing 2, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
THUMP domain containing 2, transcript variant X5
THUMP domain containing 2, transcript variant X3
THUMP domain containing 2, transcript variant X4
THUMP domain-containing protein 2 isoform X1
THUMP domain-containing protein 2 isoform X3
THUMP domain containing 2, transcript variant X2
THUMP domain-containing protein 2 isoform X2
solute carrier family 8 member A1, transcript variant X22
solute carrier family 8 member A1, transcript variant X19
solute carrier family 8 member A1, transcript variant X16
solute carrier family 8 member A1, transcript variant X14
solute carrier family 8 member A1, transcript variant X10
solute carrier family 8 member A1, transcript variant X17
solute carrier family 8 member A1, transcript variant X9
solute carrier family 8 member A1, transcript variant X8
solute carrier family 8 member A1, transcript variant X6
solute carrier family 8 member A1, transcript variant X13
solute carrier family 8 member A1, transcript variant X7
solute carrier family 8 member A1, transcript variant X5
solute carrier family 8 member A1, transcript variant X23
solute carrier family 8 member A1, transcript variant X1
solute carrier family 8 member A1, transcript variant X21
solute carrier family 8 member A1, transcript variant X18
solute carrier family 8 member A1, transcript variant X12
solute carrier family 8 member A1, transcript variant X20
solute carrier family 8 member A1, transcript variant X15
solute carrier family 8 member A1, transcript variant X11
solute carrier family 8 member A1, transcript variant X4
solute carrier family 8 member A1, transcript variant X2
solute carrier family 8 member A1, transcript variant X3
solute carrier family 8 member A1, transcript variant X28
solute carrier family 8 member A1, transcript variant X26
solute carrier family 8 member A1, transcript variant X25
solute carrier family 8 member A1, transcript variant X27
solute carrier family 8 member A1, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial ribosomal protein S5, transcript variant X2
28S ribosomal protein S5, mitochondrial isoform X2
mitochondrial ribosomal protein S5, transcript variant X3
28S ribosomal protein S5, mitochondrial isoform X3
mitochondrial ribosomal protein S5, transcript variant X4
28S ribosomal protein S5, mitochondrial isoform X4
mitochondrial ribosomal protein S5, transcript variant X1
mitochondrial ribosomal protein S5, transcript variant X5
28S ribosomal protein S5, mitochondrial isoform X1
28S ribosomal protein S5, mitochondrial isoform X5
mal, T cell differentiation protein, transcript variant X2
mal, T cell differentiation protein, transcript variant X1
myelin and lymphocyte protein isoform X2
myelin and lymphocyte protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/arginine-rich splicing factor 7-like
gem nuclear organelle associated protein 6
serine and arginine rich splicing factor 7, transcript variant X5
serine and arginine rich splicing factor 7, transcript variant X3
serine and arginine rich splicing factor 7, transcript variant X2
serine and arginine rich splicing factor 7, transcript variant X1
serine and arginine rich splicing factor 7, transcript variant X6
serine and arginine rich splicing factor 7, transcript variant X4
serine/arginine-rich splicing factor 7 isoform X4
serine/arginine-rich splicing factor 7 isoform X6
serine/arginine-rich splicing factor 7 isoform X1
serine/arginine-rich splicing factor 7 isoform X3
serine/arginine-rich splicing factor 7 isoform X2
serine/arginine-rich splicing factor 7 isoform X5
galactose mutarotase, transcript variant X3
galactose mutarotase, transcript variant X1
galactose mutarotase, transcript variant X6
galactose mutarotase, transcript variant X4
galactose mutarotase, transcript variant X2
galactose mutarotase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein L like, transcript variant X2
heterogeneous nuclear ribonucleoprotein L like, transcript variant X1
heterogeneous nuclear ribonucleoprotein L-like isoform X1
heterogeneous nuclear ribonucleoprotein L-like isoform X2
atlastin GTPase 2, transcript variant X3
atlastin GTPase 2, transcript variant X4
atlastin GTPase 2, transcript variant X1
atlastin GTPase 2, transcript variant X2
eukaryotic translation initiation factor 4A3
GINS complex subunit 1, transcript variant X1
GINS complex subunit 1, transcript variant X2
DNA replication complex GINS protein PSF1 isoform X1
DNA replication complex GINS protein PSF1 isoform X2
abhydrolase domain containing 12, lysophospholipase, transcript variant X2
lysophosphatidylserine lipase ABHD12 isoform X2
abhydrolase domain containing 12, lysophospholipase, transcript variant X1
lysophosphatidylserine lipase ABHD12 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glycogen phosphorylase, brain form
ectonucleoside triphosphate diphosphohydrolase 6, transcript variant X3
ectonucleoside triphosphate diphosphohydrolase 6, transcript variant X1
ectonucleoside triphosphate diphosphohydrolase 6, transcript variant X2
ectonucleoside triphosphate diphosphohydrolase 6 isoform X2
ectonucleoside triphosphate diphosphohydrolase 6 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: visual system homeobox 1
acyl-CoA synthetase short chain family member 1, transcript variant X2
acyl-CoA synthetase short chain family member 1, transcript variant X1
acyl-CoA synthetase short chain family member 1, transcript variant X3
acyl-CoA synthetase short chain family member 1, transcript variant X4
acyl-CoA synthetase short chain family member 1, transcript variant X5
acetyl-coenzyme A synthetase 2-like, mitochondrial isoform X1
acetyl-coenzyme A synthetase 2-like, mitochondrial isoform X3
acetyl-coenzyme A synthetase 2-like, mitochondrial isoform X4
acetyl-coenzyme A synthetase 2-like, mitochondrial isoform X2
acetyl-coenzyme A synthetase 2-like, mitochondrial isoform X5
adipocyte plasma membrane associated protein, transcript variant X2
adipocyte plasma membrane associated protein, transcript variant X3
adipocyte plasma membrane-associated protein isoform X2
adipocyte plasma membrane associated protein, transcript variant X1
adipocyte plasma membrane-associated protein isoform X1
synapse differentiation inducing 1, transcript variant X1
synapse differentiation inducing 1, transcript variant X2
synapse differentiation-inducing gene protein 1
BUB1 mitotic checkpoint serine/threonine kinase
mitotic checkpoint serine/threonine-protein kinase BUB1
anaphase promoting complex subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
anaphase promoting complex subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
anaphase promoting complex subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
anaphase-promoting complex subunit 1 isoform X3
anaphase-promoting complex subunit 1 isoform X2
anaphase-promoting complex subunit 1 isoform X1
MER proto-oncogene, tyrosine kinase, transcript variant X1
MER proto-oncogene, tyrosine kinase, transcript variant X2
zinc finger CCCH-type containing 6, transcript variant X2
zinc finger CCCH-type containing 6, transcript variant X1
zinc finger CCCH domain-containing protein 6 isoform X1
zinc finger CCCH-type containing 6, transcript variant X3
zinc finger CCCH domain-containing protein 6 isoform X3
zinc finger CCCH domain-containing protein 6 isoform X2
catenin alpha-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
catenin alpha-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
catenin alpha-2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
catenin alpha-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
catenin alpha-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC101933606 isoform X1
uncharacterized protein LOC101933606 isoform X3
tubulin tyrosine ligase, transcript variant X2
tubulin tyrosine ligase, transcript variant X1
RNA polymerase I subunit B, transcript variant X3
RNA polymerase I subunit B, transcript variant X4
RNA polymerase I subunit B, transcript variant X2
DNA-directed RNA polymerase I subunit RPA2 isoform X2
RNA polymerase I subunit B, transcript variant X1
DNA-directed RNA polymerase I subunit RPA2 isoform X1
DNA-directed RNA polymerase I subunit RPA2 isoform X3
RNA polymerase I subunit B, transcript variant X5
DNA-directed RNA polymerase I subunit RPA2 isoform X4
uncharacterized LOC103306011, transcript variant X2
uncharacterized LOC103306011, transcript variant X1
protein phosphatase 2 regulatory subunit B'delta, transcript variant X1
protein phosphatase 2 regulatory subunit B'delta, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform
kelch domain containing 3, transcript variant X1
kelch domain containing 3, transcript variant X6
kelch domain containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
kelch domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
kelch domain containing 3, transcript variant X2
kelch domain containing 3, transcript variant X3
kelch domain-containing protein 3 isoform X1
kelch domain-containing protein 3 isoform X2
neuronal PAS domain-containing protein 4-like, transcript variant X2
neuronal PAS domain-containing protein 4-like, transcript variant X1
neuronal PAS domain-containing protein 4-like, transcript variant X3
neuronal PAS domain-containing protein 4-like isoform X1
neuronal PAS domain-containing protein 4-like isoform X2
ribosomal RNA processing protein 36 homolog
phosphofurin acidic cluster sorting protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 75 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
mitochondrial ribosomal protein L2, transcript variant X1
39S ribosomal protein L2, mitochondrial isoform X1
mitochondrial ribosomal protein L2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
39S ribosomal protein L2, mitochondrial isoform X2
kinesin light chain 4, transcript variant X3
kinesin light chain 4, transcript variant X2
kinesin light chain 4, transcript variant X1
kinesin light chain 4, transcript variant X8
kinesin light chain 4, transcript variant X7
kinesin light chain 4, transcript variant X9
kinesin light chain 4, transcript variant X10
kinesin light chain 4, transcript variant X11
kinesin light chain 4, transcript variant X12
kinesin light chain 4, transcript variant X6
kinesin light chain 4, transcript variant X4
kinesin light chain 4, transcript variant X5
heme-binding protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
heme-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
heme-binding protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
serum response factor, transcript variant X1
serum response factor, transcript variant X2
serum response factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00002
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
IGF like family receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
IGF like family receptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
histone-lysine N-methyltransferase 2B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
zinc finger and BTB domain containing 32
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain-containing protein 32
presenilin enhancer, gamma-secretase subunit, transcript variant X1
presenilin enhancer, gamma-secretase subunit, transcript variant X3
gamma-secretase subunit PEN-2 isoform X1
presenilin enhancer, gamma-secretase subunit, transcript variant X2
gamma-secretase subunit PEN-2 isoform X2
heat shock protein family B (small) member 6, transcript variant X1
heat shock protein family B (small) member 6, transcript variant X2
lin-37 DREAM MuvB core complex component, transcript variant X4
lin-37 DREAM MuvB core complex component, transcript variant X1
lin-37 DREAM MuvB core complex component, transcript variant X3
lin-37 DREAM MuvB core complex component, transcript variant X2
proline and serine rich 3, transcript variant X6
proline and serine rich 3, transcript variant X4
proline and serine rich 3, transcript variant X5
proline and serine rich 3, transcript variant X1
proline and serine-rich protein 3 isoform X5
proline and serine-rich protein 3 isoform X4
proline and serine-rich protein 3 isoform X1
proline and serine rich 3, transcript variant X3
proline and serine rich 3, transcript variant X2
proline and serine-rich protein 3 isoform X2
proline and serine-rich protein 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
amyloid beta precursor like protein 1, transcript variant X2
amyloid beta precursor like protein 1, transcript variant X1
kirre like nephrin family adhesion molecule 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
kirre like nephrin family adhesion molecule 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
NFKB inhibitor delta, transcript variant X2
NFKB inhibitor delta, transcript variant X3
NFKB inhibitor delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 42% coverage of the annotated genomic feature by RNAseq alignments